Ledger.Open graph →
SEC Form D · filed May 1, 2025

Mivax Therapeutics, Inc

Offering
—
Sold
$108K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Francisco, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Viraj B. Deshpande · San Francisco, CAExecPragyesh B. Dhungel · San Francisco, CAExecViraj B. Deshpande · San Francisco, CAExecPragyesh B. Dhungel · San Francisco, CAExecHelen Koo · San Francisco, CAExecMatthew Colpoys · Buffalo, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗